Are Ian Sheffield’s FRACTYL HEALTH (GUTS) transactions open-market or compensation-related?

His Form 4 shows both types: a 35,000-share open-market purchase of Fractyl Health common stock and a 22,500-share stock option grant. The option award is compensation for his board service under the company’s non-employee director compensation policy.

Fractyl Health director buys 35K shares

FRACTYL HEALTH, INC. director Ian Sheffield reported an open-market purchase and an option grant.

Filing Impact

(Moderate)

Filing Sentiment

(Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

FRACTYL HEALTH, INC. director Ian Sheffield reported an open-market purchase and an option grant. He bought 35,000 shares of Common Stock at $0.7294 per share, giving him 35,000 shares held directly after the transaction.

He was also granted 22,500 stock options with an exercise price of $0.7318 per share, each for one share of Common Stock and expiring on June 9, 2036. The option vests in a single installment on the earlier of the next annual stockholder meeting or the first anniversary of the grant, subject to his continued service on the board as a non-employee director.

Insider Trade Summary

Net Buyer: 35,000 shares

Net Buy 2 txns

Insider Sheffield Ian

Role Director

Bought 35,000 shs ($26K)

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	22,500	$0.00	$0.00
Purchase	Common Stock	35,000	$0.7294	$26K

Holdings After Transaction: Stock Option — 22,500 contracts (Direct); Common Stock — 35,000 shares (Direct)

Footnotes (2)

F1. Open market purchase.
F2. The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.

Key Figures

Open-market purchase: 35,000 shares Purchase price: $0.7294 per share Shares held after trade: 35,000 shares +3 more

6 metrics

Open-market purchase 35,000 shares Common Stock bought on June 10, 2026

Purchase price $0.7294 per share Price for 35,000 Common Stock shares

Shares held after trade 35,000 shares Direct Common Stock ownership following transaction

Stock options granted 22,500 options Awarded as non-employee director compensation

Option exercise price $0.7318 per share Exercise price for 22,500 options

Option expiration June 9, 2036 Expiry date of stock option grant

Key Terms

open-market purchase, Stock Option, non-employee director compensation policy

3 terms

open-market purchase financial

"Open market purchase."

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Stock Option financial

"The stock option was awarded as compensation for the Reporting Person's service"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

non-employee director compensation policy financial

"pursuant to the Issuer's non-employee director compensation policy."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Ian Sheffield report for FRACTYL HEALTH (GUTS)?

Ian Sheffield reported buying 35,000 shares of Fractyl Health common stock and receiving 22,500 stock options. The share purchase was an open-market transaction, and the options were granted as compensation for his service on the company’s board of directors.

How many FRACTYL HEALTH (GUTS) shares did Ian Sheffield buy and at what price?

Ian Sheffield bought 35,000 shares of Fractyl Health common stock at $0.7294 per share in an open-market transaction. Following this purchase, he directly owned 35,000 common shares according to the reported Form 4 insider trading disclosure.

What are the details of Ian Sheffield’s stock option grant at FRACTYL HEALTH (GUTS)?

Ian Sheffield received 22,500 stock options for Fractyl Health common stock with a $0.7318 exercise price per share. These options expire on June 9, 2036 and were granted as compensation for his service on the company’s board of directors.

When do Ian Sheffield’s FRACTYL HEALTH (GUTS) stock options vest?

Ian Sheffield’s Fractyl Health stock options vest in a single installment on the earlier of the next annual stockholder meeting or the first anniversary of the grant, provided he continues serving as a non-employee director on the company’s board through the vesting date.

How many FRACTYL HEALTH (GUTS) shares underlie Ian Sheffield’s stock options?

Ian Sheffield’s stock option grant covers 22,500 shares of Fractyl Health common stock. Each option is exercisable for one common share at an exercise price of $0.7318, giving him potential additional equity exposure if the options vest and are exercised.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/11/2026 - 05:00 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sheffield Ian

(Last)

(First)

(Middle)

3 VAN DE GRAAFF DRIVE

SUITE 200

(Street)

BURLINGTON

MASSACHUSETTS

01803

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FRACTYL HEALTH, INC. [ GUTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/10/2026		P⁽¹⁾		35,000	A	$0.7294	35,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option	$0.7318	06/10/2026		A		22,500		⁽²⁾	06/09/2036	Common Stock	22,500	$0	22,500	D

Explanation of Responses:

1. Open market purchase.

2. The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.

	/s/ Harith Rajagopalan, M.D., Ph.D., Attorney-in-fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR